‘$7.9 trillion’ savings from earlier Alzheimer’s diagnosis: Is there a hidden agenda behind the numbers?
Video game therapy for ADHD: News touts a ‘landmark’ study but nobody has seen it
Four questions to ask when reading or writing about water fluoridation and IQ
Ending journalism’s bad trip — why it’s important to communicate responsibly about the health effects of psychedelic drugs
Off-label drug marketing: Who will decide what’s “truthful” when the evidence can’t be trusted?
Poking holes in Pokémon Go health benefit claims–including a study that didn’t exist
What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug
Inside the Sausage Factory of Drug Approval: Nuplazid (pimavanserin) coverage didn’t inspect closely enough
TIME’s short memory on Alzheimer’s drug failures
Missing in action: Did US journalists miss a huge opportunity to critically examine mental health screening?